BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 12450424)

  • 21. Prognostic and predictive value of the thymidylate synthase expression in patients with non-metastatic colorectal cancer.
    Aguiar S; Lopes A; Soares FA; Rossi BM; Ferreira FO; Nakagawa WT; Carvalho AL; Filho WJ
    Eur J Surg Oncol; 2005 Oct; 31(8):863-8. PubMed ID: 15923105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thymidylate synthase activity after preoperative administration of 5-FU in patients with gastric or colorectal cancer].
    Arima S; Tachikawa D; Kawahara K; Futami K
    Gan To Kagaku Ryoho; 2000 May; 27(5):703-10. PubMed ID: 10832438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxymethylglutaryl-coenzyme a synthase 2 expression is associated with chemoradiotherapy responses in colorectal cancer.
    Yeo SG; Kim DY; Kim KH; Ku JL; Kim JS; Cho MJ; Kim ES; Yoo BC
    Dis Colon Rectum; 2012 Jun; 55(6):686-94. PubMed ID: 22595849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer.
    Xi Y; Formentini A; Nakajima G; Kornmann M; Ju J
    Oncol Rep; 2008 Jan; 19(1):257-62. PubMed ID: 18097604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil.
    Iacopetta B; Grieu F; Joseph D; Elsaleh H
    Br J Cancer; 2001 Sep; 85(6):827-30. PubMed ID: 11556832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression level of thymidylate synthase is a good predictor of chemosensitivity to 5-fluorouracil in colorectal cancer.
    Inoue T; Hibi K; Nakayama G; Komatsu Y; Fukuoka T; Kodera Y; Ito K; Akiyama S; Nakao A
    J Gastroenterol; 2005 Feb; 40(2):143-7. PubMed ID: 15770397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thymidylate synthase was associated with patient prognosis and the response to adjuvant therapy in bladder cancer.
    Li Y; Li X; Dai H; Sun X; Li J; Yang F; Gu H; Yang Y; Jin Z; Chu Y; Jin X; Kakehi Y; Wu X
    BJU Int; 2009 Feb; 103(4):547-52. PubMed ID: 18990150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
    Yamada H; Iinuma H; Watanabe T
    Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.
    Kinoshita M; Kodera Y; Hibi K; Nakayama G; Inoue T; Ohashi N; Ito Y; Koike M; Fujiwara M; Nakao A
    Anticancer Res; 2007; 27(2):851-6. PubMed ID: 17465211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Kornmann M; Schwabe W; Sander S; Kron M; Sträter J; Polat S; Kettner E; Weiser HF; Baumann W; Schramm H; Häusler P; Ott K; Behnke D; Staib L; Beger HG; Link KH
    Clin Cancer Res; 2003 Sep; 9(11):4116-24. PubMed ID: 14519634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Where should the specimen be excised for the chemosensitivity of colorectal cancer to 5-fluorouracil?
    Ushigome T; Kawahara H; Kobayashi T; Kobayashi S; Kashiwagi H; Yanaga K
    Hepatogastroenterology; 2010; 57(102-103):1090-4. PubMed ID: 21410037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of expression of ERCC 1 and GST-p for 5-fluorouracil/oxaliplatin chemotherapy in advanced colorectal cancer.
    Noda E; Maeda K; Inoue T; Fukunaga S; Nagahara H; Shibutani M; Amano R; Nakata B; Tanaka H; Muguruma K; Yamada N; Yashiro M; Ohira M; Ishikawa T; Hirakawa K
    Hepatogastroenterology; 2012; 59(113):130-3. PubMed ID: 21940361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene.
    Kawakami K; Watanabe G
    Cancer Res; 2003 Sep; 63(18):6004-7. PubMed ID: 14522928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of elevation of plasma 2'-deoxyuridine, a surrogate marker of thymidylate synthase (TS) inhibition, after administration of two different schedules of 5-fluorouracil and the specific TS inhibitors raltitrexed (Tomudex) and ZD9331.
    Ford HE; Mitchell F; Cunningham D; Farrugia DC; Hill ME; Rees C; Calvert AH; Judson IR; Jackman AL
    Clin Cancer Res; 2002 Jan; 8(1):103-9. PubMed ID: 11801545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of thymidylate synthase: biochemical pharmacology of drugs with activity in colorectal cancer.
    Jackman AL
    Tumori; 1997; 83(1 Suppl):S65-6. PubMed ID: 9154072
    [No Abstract]   [Full Text] [Related]  

  • 36. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.
    Salonga D; Danenberg KD; Johnson M; Metzger R; Groshen S; Tsao-Wei DD; Lenz HJ; Leichman CG; Leichman L; Diasio RB; Danenberg PV
    Clin Cancer Res; 2000 Apr; 6(4):1322-7. PubMed ID: 10778957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53, DCC and thymidylate synthase as predictors of survival after resection of hepatic metastases from colorectal cancer.
    Saw RP; Koorey D; Painter D; Gallagher PJ; Solomon MJ
    Br J Surg; 2002 Nov; 89(11):1409-15. PubMed ID: 12390383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymidylate synthase levels: prognostic, predictive, or both?
    Allegra C
    J Clin Oncol; 2002 Apr; 20(7):1711-3. PubMed ID: 11919223
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
    Kralovánszky J; Adleff V; Hitre E; Pap E; Réti A; Komlósi V; Budai B
    Magy Onkol; 2007; 51(2):113-25. PubMed ID: 17660867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thymidylate synthase expression in colorectal cancer: the never-ending story.
    Vincenzi B; Santini D; Tonini G
    J Clin Oncol; 2005 Mar; 23(9):2108; author reply 2108-9. PubMed ID: 15774806
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.